What the company’s own results press releases said it expected, in its words, and what it later filed for the same period. Earnings per share and revenue stated as amounts; guidance given as a growth rate is not read. Back to SMCI earnings
Read from 3 results releases filed 2026-05-05 to 2026-11-03; updated 2026-11-08.
For fiscal year 2027, the Company expects net sales in the range of $65.0 billion to $72.0 billion.
For fiscal year 2027, the Company expects net sales in the range of $72.0 billion to $82.0 billion.
Not paired: fiscal 2027 has not ended on a calendar reading of its label, or its report is not filed yet (checked 2026-11-08).
The Company expects net sales in the range of $19.5 billion and $21.5 billion for the second quarter of fiscal year 2027 ending December 31, 2026, GAAP net income per diluted share of $1.59 to $1.83 and non-GAAP net income per diluted share of $1.66 to $1.90.
Not paired: Q2 of fiscal 2027 has not ended on a calendar reading of its label, or its report is not filed yet (checked 2026-11-08).
The Company expects net sales in the range of $19.5 billion and $21.5 billion for the second quarter of fiscal year 2027 ending December 31, 2026, GAAP net income per diluted share of $1.59 to $1.83 and non-GAAP net income per diluted share of $1.66 to $1.90.
Not paired: Q2 of fiscal 2027 has not ended on a calendar reading of its label, or its report is not filed yet (checked 2026-11-08).
The Company expects net sales in the range of $14.5 billion and $15.5 billion for the first quarter of fiscal year 2027 ending September 30, 2026, GAAP net income per diluted share of $0.89 to $0.98 and non-GAAP net income per diluted share of $1.01 to $1.10.
Not paired: Q1 of fiscal 2027 has not ended on a calendar reading of its label, or its report is not filed yet (checked 2026-11-08).
The Company expects net sales in the range of $14.5 billion and $15.5 billion for the first quarter of fiscal year 2027 ending September 30, 2026, GAAP net income per diluted share of $0.89 to $0.98 and non-GAAP net income per diluted share of $1.01 to $1.10.
Reported: 1.75 USD per share, 10-Q filed 2026-11-06, period ended 2026-09-30 (the filing)
For fiscal year 2026, the Company expects net sales in the range of $38.9 billion to $40.4 billion.
Not paired: fiscal 2026 has not ended on a calendar reading of its label, or its report is not filed yet (checked 2026-11-08).
The Company expects net sales in the range of $11.0 billion and $12.5 billion for the fourth quarter of fiscal year 2026 ending June 30, 2026, GAAP net income per diluted share of $0.53 to $0.67 and non-GAAP net income per diluted share of $0.65 to $0.79.
Not paired: a full-year or fourth-quarter adjusted figure would come from the fourth-quarter release, and this register does not match that release to a period.
The Company expects net sales in the range of $11.0 billion and $12.5 billion for the fourth quarter of fiscal year 2026 ending June 30, 2026, GAAP net income per diluted share of $0.53 to $0.67 and non-GAAP net income per diluted share of $0.65 to $0.79.
Not paired: a fourth quarter has no three-month figure of its own in XBRL; the annual report files the full year only.
How this is read: a guidance figure is kept only when its sentence or table row names the measure, the period and an amount, and a revision’s current range is the one its own words mark as current. Measured 2026-11-05 on 71 results releases read by hand: it printed 56 guidance items, all of them right, and left out 19 of the 75 the documents state, because its rules abstain rather than guess. GAAP figures and revenue are paired with the company’s XBRL; an adjusted figure with the release whose 10-Q names the same quarter. This is what the company said and filed, not a forecast of ours, and nothing here is a recommendation to buy, sell or hold SMCI.